TGFB1 and geroderma osteodysplastica: Since TGF-β plays a crucial role in the pathogenesis of GO, including tissue fibrosis, ECM accumulation, and orbital remodeling, various therapeutic strategies have been investigated to target TGF-β signaling pathways in GO treatment.